Angewandte
Chemie
DOI: 10.1002/anie.201310767
Asymmetric Catalysis
Catalytic, Enantioselective Synthesis of 1,2-anti-Diols by Asymmetric
Ring-Opening/Cross-Metathesis**
John Hartung and Robert H. Grubbs*
Abstract: An enantioselective method for the synthesis of 1,2-
anti-diols has been developed. A cyclometalated chiral-at-
ruthenium complex catalyzes the asymmetric ring-opening/
cross-metathesis of dioxygenated cyclobutenes, thus resulting
in functionally rich synthetic building blocks. Syntheses of the
insect pheromone (+)-endo-brevicomin and monosaccharide
ribose demonstrate the synthetic utility of the 1,2-anti-diol
fragments generated in the title reaction.
Scheme 1. AROCM reaction to afford highly enantioenriched 1,2-anti-
T
he formation of multiple stereocenters in a single catalytic
diols.
transformation is a powerful approach to the synthesis of
stereochemically complex targets. While the development of
such a transformation must overcome the challenge of
simultaneously controlling diastereo- and enantioselectivity,
the end result can reduce the step count of a synthesis and
improve its atom economy. One commonly encountered
motif is the vicinal diol, which is found in natural products and
ligands for asymmetric transformations. While the problem of
introducing vicinal diols in high enantiopurity has largely
been solved by the Sharpless asymmetric dihydroxylation
(AD), the formation of 1,2-anti-diols remains challenging
because of the low enantioselectivity observed in the AD of
cis-1,2-disubstituted alkenes.[1] Accordingly, a number of
methods have been developed for the enantioselective
formation of 1,2-anti diols, including asymmetric epoxida-
tion/hydrolysis,[2] glycolate aldol,[3] iterative cross-metathesis/
allylic substitution,[4] nucleophilic addition to aldehydes,[5]
desymmetrizing monofunctionalization,[6] and allene hydro-
boration/aldehyde allylation.[7] In contrast to many of these
methods, an asymmetric ring-opening/cross-metathesis
(AROCM) approach (Scheme 1) would consolidate the
transformation into a single step and generate a differentiated
1,5-diene fragment in a convergent manner.
diastereo-[9] and enantioselectivity.[10] Although the ROCM of
cyclobutenes to form racemic products has been demonstra-
ted,[9f,11] previous studies of their AROCM reactions have
afforded products with low enantioenrichment.[10i]
It was envisioned that the desymmetrization of suitably
substituted meso-cyclobutenes by AROCM would afford the
1,2-anti-diol motif in perfect anti diastereoselectivity and
potentially high enantioselectivity upon application of
a newly developed cyclometalated metathesis catalyst (1,
Scheme 1).[12] The resultant 1,5-diene would be a versatile
synthetic intermediate because of the differential reactivity of
the two alkenes, thus paving the way for further chemo-
selective transformations. Herein, we report the successful
application of 1 to afford highly enantioenriched 1,2-anti-diols
and demonstrate the versatility of these products in the
synthesis of the insect pheromone (+)-endo-brevicomin and
a derivative of the monosaccharide l-ribose. Pest control
strategies utilizing insect pheromones have become a promis-
ing alternative to the application of broad-spectrum insecti-
cides, thus underscoring the importance of rapid synthetic
routes to (+)-endo-brevicomin and related bioactive com-
pounds.[13,14]
Initial attempts to form 1,2-anti-diols were carried out
with 1, allyl acetate (3), and cis-3,4-dibenzyloxycyclobutene
(2; Table 1), which was synthesized by substitution of
commercially available cis-3,4-dichlorocyclobutene with
sodium phenylmethanolate.[15] The solvent had no effect on
the selectivity of the AROCM reaction except for slightly
diminished enantioselectivity in CH2Cl2 (entry 1). The yield
was highest in THF (entry 4). The effect of stoichiometry in
AROCM has been explored for a number of catalysts.[10b,i,16]
In the current study, an excess of the terminal olefin was
optimal (7 equiv, entry 4). As the number of equivalents of
terminal olefin were reduced, the yield of the reaction fell, yet
a modest yield of 29% could be obtained with 1.2 equivalents
of 3. No bis(cross-product) was observed. Reducing the
concentration also resulted in lower yield, thus leading to the
optimal reaction conditions, which involve 7 equivalents of 3
À
Asymmetric olefin metathesis is a powerful C C bond-
forming reaction and has enabled the synthesis of stereo-
chemically complex bioactive compounds.[8] Advances in
stereoselective olefin metathesis have resulted in the devel-
opment of catalysts capable of forming products with high
[*] Dr. J. Hartung, Prof. R. H. Grubbs
Division of Chemistry and Chemical Engineering
California Institute of Technology, Pasadena, CA 91125 (USA)
E-mail: rhg@caltech.edu
[**] This work was financially supported by the NIH (5R01GM031332-27
to R.H.G.) and the NSF (CHE-1048404 to R.H.G.). We thank
Materia, Inc. for donation of metathesis catalysts and Dr. Jeffrey
Cannon, Dr. Bill Morandi, and Zach K. Wickens for helpful
discussion.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2014, 53, 3885 –3888
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3885